National Academies Press: OpenBook

Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology (1992)

Chapter: Research Protocol for Clinical Evaluation

« Previous: Introduction
Suggested Citation:"Research Protocol for Clinical Evaluation." National Research Council. 1992. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: The National Academies Press. doi: 10.17226/1988.
×

OVERVIEW

To develop a research agenda on multiple chemical sensitivity syndrome, participants were assigned to three multi-disciplinary groups. The groups were asked to focus on: 1) the design of a research protocol for clinical evaluation; 2) studies to evaluate relevant exposures and mechanisms; and 3) epidemiologic approaches. The specific charges were:

  • Development of a Working Definition for the Syndrome

  • Evaluation of All Potential Causes

  • Evaluation of Uncertainties Associated with the Data and Data Gaps

  • Preparation of Report on Research Recommendations and Protocol

The reports of the three working groups follow. Because consensus was achieved within each group on the substance and language of the recommendations, the reports are presented unedited, as accepted at the workshop.

Research Protocol for Clinical Evaluation

WORKING GROUP I

The group agreed that patients have been identified with a condition of multiple and often diverse symptoms that have been attributed to chemical agents in the environment. These patients may have recognized disease syndromes. However, symptomatology related to multiple chemicals is a distinct feature of these patients that is not classifiable by existing criteria used in conventional medical practice for psychiatric or physical illness. Thus, this feature cannot be uniquely coded in either DSM-III-R or ICD-9.

CASE CRITERIA

Criteria for the selection of cases for evaluation of multiple chemical sensitivity were discussed, and the committee agreed on criteria for research purposes as discussed below (definitions for other purposes were not addressed by this group):

Suggested Citation:"Research Protocol for Clinical Evaluation." National Research Council. 1992. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: The National Academies Press. doi: 10.17226/1988.
×
  1. Sensitivity to chemicals. By sensitivity we mean symptoms or signs related to chemical exposures at levels tolerated by the population at large that is distinct from such well recognized hypersensitivity phenomena as IgE-mediated immediate hypersensitivity reactions, contact dermatitis, and hypersensitivity pneumonitis.

  2. Sensitivity may be expressed as symptoms and signs in one or more organ systems.

  3. Symptoms and signs wax and wane with exposures. It is not necessary to identify a chemical exposure associated with the onset of the condition. Preexistent or concurrent conditions, e.g. asthma, arthritis, somatization disorder or depression, should not exclude patients from consideration.

CANDIDATE POPULATIONS

The selection of subjects for research protocols will depend on the specific hypotheses to be tested. Identifiable populations include but are not restricted to:

  1. Symptom or sign based: Patients with reactivity to environmental chemicals, either through serf-reporting or meeting case selection criteria.

  2. Disease based: Patients with specific diseases that are suspected to be caused by or exacerbated by chemical exposures.

  3. Exposure based: Groups characterized by a common exposure, such as workers at a specific factory, occupants of a particular building, or residents of a contaminated community.

  4. Population based: Groups such as school children or a random community sample.

Appropriate comparison groups should be chosen in each case.

EVALUATION

Research design and methods should be chosen as appropriate for each hypothesis. However, a minimum uniform data base across these groups needs to be developed which shall include the items in Table One. Specialized evaluations need to be developed for investigating specific hypotheses as listed in Table Two. It is beyond the scope of this committee to develop these in detail.

A research priority will be the study of the adaptation-deadaptation hypothesis, and this study must be conducted at an early stage because the outcome of this investigation will influence future study design. An environmental control unit, a clinical research unit in which subjects are housed for the control of exposures to foods and chemicals, should be developed to study the adaptation-deadaptation hypothesis. Other possible uses of units would include control of exposures and challenging subjects ha a well-defined environment. Use of this modality will be very complex, and its indications and use must be researched and tested in detail. Other modalities of testing such as challenge chamber studies will have utility, and also must be studied in detail.

Prospective longitudinal studies of exposure based events are very important and should be performed.

Suggested Citation:"Research Protocol for Clinical Evaluation." National Research Council. 1992. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: The National Academies Press. doi: 10.17226/1988.
×

TABLE 1

Uniform Core Database

history of sensitivity to foods, chemicals, and drugs

age

gender

marital status

race

education

dietary history

socioeconomic status

standardized medical evaluation

occupational history

environmental and exposure history

smoking history

medication history

alcohol and drug use history

psychological screening

atopy

TABLE 2

Specialized Evaluations

Nutritional assessment

Metabolic phenotype

Psychological profile

Neuropsychological profile

Assessment of cell-mediated immunity

HLA haplotype

Provocative challenge

Bronchial hyperreactivity

Autonomic tone

Other immunological assessment

Other neurological assessment

Suggested Citation:"Research Protocol for Clinical Evaluation." National Research Council. 1992. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: The National Academies Press. doi: 10.17226/1988.
×
This page in the original is blank.
Suggested Citation:"Research Protocol for Clinical Evaluation." National Research Council. 1992. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: The National Academies Press. doi: 10.17226/1988.
×
Page 5
Suggested Citation:"Research Protocol for Clinical Evaluation." National Research Council. 1992. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: The National Academies Press. doi: 10.17226/1988.
×
Page 6
Suggested Citation:"Research Protocol for Clinical Evaluation." National Research Council. 1992. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: The National Academies Press. doi: 10.17226/1988.
×
Page 7
Suggested Citation:"Research Protocol for Clinical Evaluation." National Research Council. 1992. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: The National Academies Press. doi: 10.17226/1988.
×
Page 8
Next: Exposures and Mechanisms »
Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology Get This Book
×
Buy Paperback | $55.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Use of the term "multiple chemical sensitivity" (MCS) as a diagnostic label has generated increasing controversy during the past few decades as a phenomenon related to exposure to chemical agents sustained both in indoor and outdoor environments.

This volume, prepared in conjunction with Biologic Markers in Immunotoxicology, contains the authored papers of a workshop held to develop an agenda to study the phenomenon of multiple chemical sensitivity. Authored by clinicians, immunologists, toxicologists, epidemiologists, psychiatrists, psychologists, and others involved in research or clinical activities relevant to the problem, the papers contain case evaluations and criteria for diagnosis, mechanisms potentially underlying MCS, and epidemiologic approaches to investigation.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!